How to increase value and reduce waste when research priorities are set
2014 · The Lancet · 1,434 citations
https://doi.org/10.1016/s0140-6736(13)62229-1
S
Silvio Garattini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.1K
Papers
26.3K
Citations
77
h-index
496
i10-index
Silvio Garattini is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Neuroscience and Neuropharmacology Research & Neurotransmitter Receptor Influence on Behavior & Health Systems, Economic Evaluations, Quality of Life. The author has an h-index of 77, co-authored 941 publications.
ORCID: 0000-0003-0647-9297Papers by this author
worksRisk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
2010 · BMC Health Services Research · 254 citations
https://doi.org/10.1186/1472-6963-10-153
Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures
2005 · British Journal of Cancer · 106 citations
https://doi.org/10.1038/sj.bjc.6602750
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies
2019 · Scientific Reports · 76 citations
https://doi.org/10.1038/s41598-018-37950-4
Enhancing the rational use of new medicines across European health care systems
2008 · European Journal of Clinical Pharmacology · 71 citations
https://doi.org/10.1007/s00228-008-0537-z
Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders
2014 · Journal of Comparative Effectiveness Research · 69 citations
https://doi.org/10.2217/cer.14.34
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat